Hypoxia augments NaHS-induced ANP secretion via KATP channel, HIF-1α and PPAR-γ pathway

Peptides. 2019 Nov:121:170123. doi: 10.1016/j.peptides.2019.170123. Epub 2019 Aug 3.

Abstract

It has been reported that sodium hydrosulfide (NaHS) stimulated high stretch induced-atrial natriuretic peptide (ANP) secretion via ATP sensitive potassium (KATP) channel. KATP channel is activated during hypoxic condition as a compensatory mechanism. However, whether NaHS affects ANP secretion during hypoxia remains obscure. The purpose of the present study is to discover the impact of NaHS on ANP secretion during hypoxia and to unravel its signaling pathway. Isolated beating rat atria were perfused with buffer exposed to different O2 tension (to 100% O2, normoxia; to 20% O2, hypoxia). The ANP secretion increased negatively correlated with O2 tension. NaHS (50 μM) did not show any significant effect on low stretch induced-ANP secretion in normoxic condition but augmented low stretch induced-ANP secretion in hypoxic condition. The augmentation of NaHS-induced ANP secretion during hypoxia was blocked by the pretreatment with KATP channel blocker (glibenclamide) and was enhanced by the pretreatment with KATP channel activator (pinacidil). Hypoxia increased the expression of PPAR-γ protein but did not change the expression of HIF-1α protein and eNOS phosphorylation. The NaHS-induced ANP secretion during hypoxia was also blocked by the pretreatment with HIF-1α inhibitor (2-methoxy- estradiol), PPAR-γ inhibitor (GW9662) but not by NOS inhibitor (L-NAME) and endothelin receptor inhibitor (bosentan). The intravenous infusion of NaHS increased plasma ANP level in monocrotaline-treated rats but not in sham rats. These results suggest that hypoxia augmented NaHS-induced ANP secretion partly through KATP channel, HIF-1α, and PPAR-γ pathway.

Keywords: Atrial natriuretic peptide; H(2)S; HIF-1α; Hypoxia; KATP channel; NaHS; PPAR-γ.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Methoxyestradiol / pharmacology
  • Anilides / pharmacology
  • Animals
  • Atrial Natriuretic Factor / genetics*
  • Atrial Natriuretic Factor / metabolism
  • Bosentan / pharmacology
  • Gene Expression Regulation
  • Glyburide / pharmacology
  • Heart Atria / drug effects
  • Heart Atria / metabolism
  • Heart Atria / physiopathology
  • Hydrogen Sulfide / chemistry
  • Hydrogen Sulfide / pharmacology
  • Hypertension, Pulmonary / chemically induced
  • Hypertension, Pulmonary / genetics
  • Hypertension, Pulmonary / metabolism*
  • Hypertension, Pulmonary / physiopathology
  • Hypoxia / genetics
  • Hypoxia / metabolism*
  • Hypoxia / physiopathology
  • Hypoxia-Inducible Factor 1, alpha Subunit / genetics*
  • Hypoxia-Inducible Factor 1, alpha Subunit / metabolism
  • KATP Channels / agonists
  • KATP Channels / antagonists & inhibitors
  • KATP Channels / genetics*
  • KATP Channels / metabolism
  • Male
  • Monocrotaline / administration & dosage
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide Synthase Type III / genetics
  • Nitric Oxide Synthase Type III / metabolism
  • Organ Culture Techniques
  • Oxygen / pharmacology
  • PPAR gamma / genetics*
  • PPAR gamma / metabolism
  • Pinacidil / pharmacology
  • Potassium Channel Blockers / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction
  • Sulfides / chemistry
  • Sulfides / pharmacology*

Substances

  • 2-chloro-5-nitrobenzanilide
  • Anilides
  • Hif1a protein, rat
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • KATP Channels
  • PPAR gamma
  • Potassium Channel Blockers
  • Sulfides
  • 2-Methoxyestradiol
  • Monocrotaline
  • Pinacidil
  • Atrial Natriuretic Factor
  • Nitric Oxide Synthase Type III
  • Nos3 protein, rat
  • sodium bisulfide
  • Bosentan
  • Oxygen
  • Glyburide
  • NG-Nitroarginine Methyl Ester
  • Hydrogen Sulfide